HELM Pharma
Finished Dosage Form Solutions
Get access to more than 150 products in our Portfolio & Pipeline, across various therapeutical areas, with different dosage forms and in different development stages.
Request Access
About us
As a B2B pharmaceutical company focused on identification and development of pharmaceutical products, with selected technology, to global markets, HELM takes you closer to your strategic success.
Our key figures
Our Portfolio
This table lists product information for reference only; it does not constitute any offer for sale.
Concentrate for solution for infusion
Calcipotriol + Betamethasone
Candesartan + Hydrochlorothiazide
8 mg + 12.5 mg, 16 mg + 12.5 mg
Powder for solution for injection/ infusion
Chlormadinone + Ethinylestradiol
Cyproterone Acetate + Ethinylestradiol
Powder for solution for injection/infusion
Dienogest + Ethinylestradiol
Drospirenone + Ethinylestradiol
3 mg + 30 μg, 3 mg + 20 μg
Film-coated tablets (vaginal)
0.1 mg, 0.2 mg, 0.4 mg, 0.6 mg, 0.8 mg
12.5 μg, 25 μg, 37.5 μg, 50 μg, 75 μg, 100 μg/h
Gestodene + Ethinylestradiol
Gestodene + Ethinylestradiol
75 μg + 20 μg, 75 μg + 30 μg
50 mg, 100 mg, 150 mg, 200 mg
250 mg, 500 mg, 750 mg, 1000 mg
25 μg / 5ml, 50 μg/ 5 ml, 100 μg/ 5ml
12.5 mg, 25 mg, 37.5 mg, 50 mg
Prolonged-release hard capsules
5 mg, 20 mg, 100 mg, 140 mg, 180 mg, 250 mg
Capsules dry powder inhaler
Powder for concentrate for solution for infusion
Products protected by valid patents are neither manufactured, or offered for sale nor marketed in jurisdictions where such activities could constitute patent infringement.
“At HELM we are committed to build solid partnerships that allow flexible business models to the development, production, and commercialization of differentiated products”
Jutta Schnirring-Mayer
Vice President Finished Dosage Forms @ HELM AG
HELM Pharma - Finished Dosage Form Solutions
Digital Portfolio
Get access to more than 150 products in our Portfolio & Pipeline, across various therapeutical areas, with different dosage forms and in different development stages.
About Us: As a B2B pharmaceutical company focused on identification and development of pharmaceutical products, with selected technology, to global markets, HELM takes you closer to your strategic success.
Our products are divided into 3 clusters:
- Standard Generics: Refer to products that are produced and marketed without any significant differentiation or unique features; Interchangeability.
- High Containment Standard Generics: Requires stringent containment measures during production, handling, and transportation.
- Differentiated and/or non substitutable generics: Improved reference product: patient centric/health care centric; Qualities or functionalities that are not easily replicated or substituted by other items in the market; Better market position possible.
“At HELM we are committed to build solid partnerships that allow flexible business models to the development, production, and commercialization of differentiated products”
Have questions or want more information about a product? Our team is ready to assist you and provide detailed information.
.svg)
